Patent · US Active

Oligonucleotides

US11104700B2 · kind B2 · utility

0Cited by
6References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 17, 2018
Grant dateAug 31, 2021
Priority date
Expiry dateSep 11, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/3341
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to novel oligonucleotides comprising at least one locked nucleoside and at least one triazole inter-nucleoside linkage linkage of Formula A or Formula B and methods of making the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.